AMRI Glasgow Ltd. is located in the United Kingdom. The site provides pre-formulation, formulation and process development services, as well as manufacture of sterile products for clinical trials
AMRI Glasgow Ltd., which is located in the United Kingdom, provides pre-formulation, formulation and process development services, as well as manufacture of sterile products for clinical trials. The site, which complements AMRI's front-end formulation expertise, is equipped with a dedicated cytotoxic suite; has extensive technical expertise and experience in the development, scale-up and GMP manufacture of liquid and lyophilized sterile dosage form products; and has the ability to work with a variety of compound categories, such as small and large molecules and controlled substances.
Core capabilities of AMRI Glasgow’s sterile injectable drug product formulation and clinical stage manufacturing services include:
Pre-formulation, Formulation & Process Development
Manufacture of Sterile Products for Clinical Trials
Analytical & Ancillary Services
Contact Details:
Albany Molecular Research Inc.
Email: Kristin.Calloway@amriglobal.com
Click here for more information about our Drug Product services.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.